Investing.com - Edwards Lifesciences (NYSE:EW) reported third quarter earnings that missed analysts' expectations on Thursday and revenue that fell short of forecasts.
The firm reported earnings per share of $0.61 on revenue of $1.32. Analysts polled by Investing.com anticipated EPS of $0.62 on revenue of $1.33B. .
Edwards Lifesciences shares lost 7.30% to trade at $80.00 in after-hours trade following the report.
For the year, Edwards Lifesciences shares are down 18%, outperforming the Nasdaq which is down 31.02% year to date.
Edwards Lifesciences follows other major Healthcare sector earnings this month
On October 14, UnitedHealth reported third quarter EPS of $5.79 on revenue of $80.9B, compared to forecasts of EPS of $5.43 on revenue of $80.52B.
J&J earnings beat analyst's expectations on October 18, with third quarter EPS of $2.55 on revenue of $23.79B. Investing.com analysts expected EPS of $2.52 on revenue of $23.46B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar